Ionis Pharmaceuticals Inc call shares owned by Simplex Trading
Quarter-by-quarter ownership of Ionis Pharmaceuticals Inc call shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Ionis Pharmaceuticals Inc call
Tip: Access up to 7 years of quarterly data
All positions including Ionis Pharmaceuticals Inc call held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ionis Pharmaceuticals Inc call by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.0M | 25k | 40.04 |
| 2024-06-30 | $4.1M | 85k | 47.66 |
| 2024-03-31 | $3.5M | 80k | 43.35 |
| 2023-12-31 | $824k | 16k | 50.55 |
| 2023-09-30 | $1.9M | 42k | 45.36 |
| 2023-06-30 | $623k | 15k | 40.99 |
| 2023-03-31 | $1.8M | 51k | 35.72 |
| 2022-12-31 | $1.4M | 38k | 37.77 |
| 2022-09-30 | $1.9M | 43k | 44.23 |
| 2022-06-30 | $903k | 24k | 37.01 |
| 2022-03-31 | $618k | 17k | 37.01 |
| 2021-12-31 | $2.6M | 66k | 40.05 |
| 2021-09-30 | $2.6M | 66k | 40.05 |
| 2021-06-30 | $2.6M | 66k | 39.88 |
| 2021-03-31 | $5.1k | 1.1k | 4.50 |
| 2020-12-31 | $5.8k | 1.0k | 5.65 |
| 2020-09-30 | $2.0k | 419 | 4.74 |
| 2020-06-30 | $1.5k | 260 | 5.89 |
| 2020-03-31 | $1.2k | 261 | 4.73 |
| 2019-12-31 | $3.0k | 499 | 6.04 |
| 2019-09-30 | $2.0k | 333 | 5.99 |
| 2019-06-30 | $1.8k | 278 | 6.42 |
| 2019-03-31 | $1.9k | 239 | 8.11 |
| 2018-12-31 | $885 | 164 | 5.40 |
| 2018-09-30 | $2.1k | 412 | 5.16 |
| 2018-06-30 | $791 | 190 | 4.16 |
| 2018-03-31 | $30k | 138 | 217.39 |
| 2017-12-31 | $89k | 382 | 232.98 |
| 2017-09-30 | $227k | 434 | 523.04 |
| 2017-06-30 | $204k | 463 | 440.60 |
| 2017-03-31 | $93k | 784 | 118.62 |
| 2016-12-31 | $370k | 640 | 578.12 |
| 2016-09-30 | $142k | 403 | 352.36 |
| 2016-06-30 | $40k | 626 | 63.90 |
| 2016-03-31 | $97k | 347 | 279.54 |
| 2015-12-31 | $583k | 356 | 1637.64 |
Top funds holding Ionis Pharmaceuticals Inc call
View all funds holding Ionis Pharmaceuticals Inc call